Abstract
Gold(I) compounds have been used in the treatment of rheumatoid arthritis for over 80 years, but the biological targets and the structure–activity relationships of these drugs are not well understood. Of particular interest is the molecular mechanism behind the antiarthritic activity of the orally available drug triethylphosphine(2,3,4,6-tetra-O-acetyl-β-1-d-thiopyranosato-S) gold(I) (auranofin, Ridaura). The cathepsin family of lysosomal, cysteine-dependent enzymes is an attractive biological target of Au(I) and is inhibited by auranofin and auranofin analogs with reasonable potency. Here we employ a combination of experimental and computational investigations into the effect of changes in the phosphine ligand of auranofin on its in vitro inhibition of cathepsin B. Sequential replacement of the ethyl substituents of triethylphosphine by phenyl groups leads to increasing potency in the resultant Au(I) complexes, due in large part to favorable interactions of the more sterically bulky Au(I)–PR3 fragments with the enzyme active site.
Similar content being viewed by others
References
Koch R (1927) Dtsch Med Wochenschr 16
Forestier J (1935) J Lab Clin Med 20:827
Empire Rheumatism Council (1961) Ann Rheum Dis 20:315
Yelin E, Wanke LA (1999) Arthritis Rheum 42:1209
Wolfe F (1996) J Rheumatol Suppl 44:13
Baker DG, Rabinowitz JL (1986) J Clin Pharmacol 26:2
Weidauer E, Yasuda Y, Biswal BK, Cherny M, James MNG, Brömme D (2007) Biol Chem 388:331
Fricker SP (1996) Gold Bull 29:53
Shaw CF III (1999) Chem Rev 99:2589
Rohozková D, Steven FS (1983) Br J Pharmacol 79:181
Paltemaa S (1968) Acta Rheum Scand 14:161
Urig S, Fritz-Wolf K, Réau R, Herold-Mende C, Tóth K, Davioud-Charvet E, Becker K (2006) Angew Chem Int Ed Engl 45:1881
Rigobello MP, Messori L, Marcon G, Agostina Cinellu M, Bragadin M, Folda A, Scutari G, Bindoli A (2004) J Inorg Biochem 98:1634
Erdogan E, Lamark T, Stallings-Mann M, Jamieson L, Pellecchia M, Thompson EA, Johansen T, Fields AP (2006) J Biol Chem 281:28450
Wang Q, Janzen N, Ramachandran C, Jirik F (1997) Biochem Pharmacol 54:703
Snyder RM, Mirabelli CK, Crooke ST (1987) Semin Arthritis Rheum 17:71
Honey K, Rudensky AY (2003) Nat Rev Immunol 3:472
Gunatilleke SS, Barrios AM (2006) J Med Chem 49:3933
Barrett AJ (1980) Biochem J 187:909
Chircorian A, Barrios AM (2004) Bioorg Med Chem Lett 14:5113
Feild MJ, Bash PA, Karplus M (1990) J Comput Chem 11:700
Singh UC, Kollman PA (1986) J Comput Chem 7:718
Warshel A, Levitt M (1976) J Mol Biol 103:227
Jorgensen WL, Tubert-Brohman I, Guimarães CRW (2004) Abstr Pap Am Chem Soc 227:U902
Tubert-Brohman I, Guimarães CRW, Jorgensen WL (2005) J Chem Theory Comput 1:817
Cornell WD, Cieplak P, Bayly CI, Gould IR, Merz KM, Ferguson DM, Spellmeyer DC, Fox T, Caldwell JW, Kollman PA (1995) J Am Chem Soc 117:5179
Case DA, Perlman DA, Caldwell JW, Chetham TE III, Ross WS, Simmerling CL, Darden TA, Merz KM, Stanton RV, Cheng AL, Vincent JJ, Crowley M, Tsui V, Gohlke H, Radmer RJ, Duan Y, Pitera J, Massova I, Seibel GL, Singh UC, Weiner PK, Kollman PA (2002) AMBER. University of California, San Francisco
Hockney RW (1968) Bull Am Phys Soc 13:1747
Berendsen HJC, Postma JPM, van Gunsteren WF, DiNola A, Haak JR (1984) J Chem Phys 81:3684
Musil D, Zucic D, Turk D, Engh RA, Mayr I, Huber R, Popovic T, Turk V, Towatari T, Katunuma N, Bode W (1991) EMBO J 10:2321
Choe Y, Leonetti F, Greenbaum DC, Lecaille F, Bogyo M, Brömme D, Ellman JA, Craik CS (2006) J Biol Chem 281:12824
LaLonde JM, Zhao B, Smith WW, Janson CA, DesJarlais RL, Tomaszek TA, Carr TJ, Thompson SK, Oh H-J, Yamashita DS, Veber DF, Abdel-Meguid SS (1998) J Med Chem 41:4567
McGrath ME (1999) Annu Rev Biophys Biomol Struct 28:181
Turk V, Turk B, Turk D (2001) EMBO J 20:4629
Tolman CA (1977) Chem Rev 77(3):313
Sutton BM, McGusty E, Walz DT, DiMartino MJ (1972) J Med Chem 15(11):1095
Whitehouse MW, Cookson PD, Siasios G, Tiekink ERT (1998) Met Based Drugs 5(4):245
Acknowledgements
A.M.B. and S.S.G. acknowledge the College of Letters, Arts and Sciences and the WiSE program at the University of Southern California for generous support. The work done by C.A.F.O. and J.A.M. was supported in part by grants from NSF, NIH, the Center for Theoretical Biological Physics, the National Biomedical Computation Resource, San Diego Supercomputing Center and Accelrys Inc.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gunatilleke, S.S., de Oliveira, C.A.F., McCammon, J.A. et al. Inhibition of cathepsin B by Au(I) complexes: a kinetic and computational study. J Biol Inorg Chem 13, 555–561 (2008). https://doi.org/10.1007/s00775-008-0344-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00775-008-0344-0